Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam dosing in painless abortion sedation
ChiCTR2000035255Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Liangshan Yi Autonomous Prefecture
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (3 arms), sponsored by The First People's Hospital of Liangshan Yi Autonomous Prefecture. Primary endpoint: MOAA/S score. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000035255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035255.